Contact PR

To use this feature, join Babbler easily !

arrow_back

Babbler is a free tool for journalists
Do not suffer news anymore, control it


By signing up you will be able to contact hundreds of press officer :
Caroline Grangie
Leboncoin
Media relation manager
Manon Guignard
Uber
Communication Associate
Sheherazade Renoux
PMU
Communication Manager

To learn more, watch the video

You're 1 click away from signing up
What is Babbler!

Previous

Nice to see you again !

Press release

SANOFI ON BEHALF OF LEXICON PHARMACEUTICALS
timer minutes reading time minute reading time

Copy link
Lexicon Pharmaceuticals announces positive 52-week results from sotagliflozin inTandem2 study presented at ADA 2018 and published in Diabetes Care
sanofi-on-behalf-of-lexicon-pharmaceuticals-1

Click to get original image size

Addressing the need for additional therapeutic options alongside insulin in type 1 diabetes

June 23, 2018

Background:

Insulin is the cornerstone of therapy for people with type 1 diabetes. But insulin-related challenges—like hypoglycemia, weight gain, and patient burden—can limit the majority of patients with T1D from reaching their target glucose levels.

  • Health & Medicine
  • Medicine
inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here

  • Health & Medicine
  • Medicine